Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Oncology · Malignant Peripheral Nerve Sheath Tumor

What Are the MPNST Warning Signs in NF1 Tumors?

At a Glance

The warning signs that a benign NF1 tumor may be turning into a cancerous MPNST include rapid growth, new or worsening pain (especially at night), a change from soft to hard texture, and new numbness or weakness. Seek immediate medical evaluation if you experience any of these red flags.

In Neurofibromatosis type 1 (NF1), it is crucial to monitor existing tumors—especially plexiform neurofibromas (large, complex nerve tumors)—for signs that they may be becoming cancerous. While most tumors in NF1 remain benign (non-cancerous), people with NF1 have an estimated 8-13% lifetime risk of one transforming into a rare, aggressive cancer called a Malignant Peripheral Nerve Sheath Tumor (MPNST) [1][2]. The main warning signs, or “red flags,” that require immediate medical attention include rapid or sudden growth of an existing tumor, new or worsening pain (especially pain that wakes you from sleep), a change in the tumor’s texture from soft to hard, and new neurological symptoms such as weakness or numbness [2][3].

The Four Clinical Red Flags

Doctors look for specific changes that suggest a benign tumor may be transforming into an MPNST. Some plexiform neurofibromas are located just under the skin, while others are deep inside the body. If you experience any of the following, contact your NF1 specialist or care team immediately [1][2]:

  • Rapid or Sudden Growth: While benign plexiform neurofibromas can grow slowly over time, a tumor that suddenly gets noticeably larger over a few weeks or months is a significant warning sign [2][3].
  • New or Worsening Pain: Many people with NF1 experience mild, chronic pain. However, you should be concerned if a previously painless tumor becomes painful, if existing pain rapidly worsens, or if you develop a deep, constant ache that disrupts your daily activities or wakes you up from sleep [3][2].
  • Change in Texture: Benign plexiform neurofibromas often feel soft, doughy, or rubbery. If a visible or easily felt tumor begins to feel unusually firm, hard, or woody, this change in consistency requires evaluation [1][4].
  • New Neurological Symptoms: Because these tumors grow along nerves, a rapidly expanding MPNST can damage the nerve it involves. This may cause new or worsening weakness, numbness, tingling, or a “pins and needles” sensation in the body part supplied by that nerve [2][3].

Note: For internal tumors that you cannot see or touch, rely primarily on paying attention to new pain or new neurological symptoms.

What Happens if You Experience a Red Flag?

If you report any of these warning signs, your doctor will likely order advanced imaging tests to evaluate the tumor. Because it is difficult to tell the difference between a benign tumor and a cancerous one based on physical symptoms alone, your care team may use:

  • PET/CT Scans: This type of imaging uses a safe radioactive sugar to see how actively the cells in the tumor are growing. Because cancer cells grow rapidly, they usually “light up” more brightly on a PET scan than benign tumors do [5][6].
  • Specialized MRI Scans: Advanced MRI techniques, such as Diffusion-Weighted MRI (DW-MRI), can help doctors see how densely packed the cells are, which helps differentiate benign tumors from malignant ones [7][8].

If the imaging suggests the tumor might be cancerous or in a “pre-cancerous” stage (known as an Atypical Neurofibromatous Neoplasm of Uncertain Biological Potential, or ANNUBP), your doctor will likely recommend a biopsy [9][1]. A biopsy is the only way to definitively confirm an MPNST diagnosis, and it typically involves using a needle to take a small tissue sample or undergoing a minor surgery [10]. If a biopsy confirms an ANNUBP, your care team may recommend close monitoring or proactive surgical removal before it can become fully malignant [1].

Proactive Monitoring

Understanding these red flags is about being empowered, not afraid. Most plexiform neurofibromas will never become MPNSTs. However, because early detection is the most important factor in successfully treating MPNSTs, vigilant self-monitoring is essential [11][12].

You should consider checking your visible and easily felt tumors once a month to establish a baseline of what is normal for you. Track changes in your existing tumors, and never hesitate to report a new symptom to your doctor. Importantly, self-monitoring is a supplement to—not a replacement for—routine (typically annual) comprehensive check-ups with an NF specialist.

Common questions in this guide

What are the red flags that an NF1 tumor is becoming cancerous?
The main warning signs include rapid or sudden growth of a tumor, new or worsening pain, a change in texture from soft to hard, and new numbness or weakness. If you notice any of these changes, you should contact your care team immediately.
How do doctors test if an NF1 tumor has turned into cancer?
Doctors typically start with advanced imaging like a PET scan or specialized MRI to see how fast the tumor cells are growing. If these scans suggest the tumor might be cancerous, they will perform a biopsy to confirm the diagnosis.
What does it mean if my neurofibroma feels hard instead of soft?
Benign plexiform neurofibromas usually feel soft, doughy, or rubbery. A change in texture where the tumor becomes unusually firm, hard, or woody is a clinical warning sign that requires immediate evaluation by your doctor.
Should I be worried if my NF1 tumor is painful?
While mild, chronic pain is common with NF1, you should be concerned if a previously painless tumor suddenly hurts or if existing pain gets rapidly worse. Pain that wakes you up from sleep or disrupts your daily activities is a significant red flag.
What is an ANNUBP?
ANNUBP stands for Atypical Neurofibromatous Neoplasm of Uncertain Biological Potential. It is considered a pre-cancerous stage where a benign tumor is starting to change, and it may require close monitoring or proactive surgical removal before it becomes fully malignant.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.If I notice one of these warning signs, who is the best person on my care team to contact for an immediate evaluation?
  2. 2.What type of routine imaging do you recommend for monitoring my internal, deep plexiform neurofibromas?
  3. 3.Do any of my current tumors have a higher risk of malignant transformation?
  4. 4.How often should I come in for my routine comprehensive NF1 check-up?
  5. 5.If I need a biopsy, will it be performed by a specialist experienced in peripheral nerve tumors?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Enlarging Plexiform Tumor in a Pregnant Patient with Neurofibromatosis Type One.

    Williams S

    Cureus 2018; (10(6)):e2802 doi:10.7759/cureus.2802.

    PMID: 30116681
  2. 2

    Rapidly Growing Malignant Peripheral Nerve Sheath Tumors Arising From Neurofibromatosis Type 1: A Case Report by Rehabilitation Physicians.

    Hayashi K, Nakaya Y, Miura T, et al.

    Cureus 2025; (17(3)):e79995 doi:10.7759/cureus.79995.

    PMID: 40182390
  3. 3

    A Case Report and Review of Diagnostic and Therapeutic Challenges of a Malignant Peripheral Nerve Sheath Tumor in the Foot.

    Vaidya K, Shinde RK, Goel S, Shah K

    Cureus 2024; (16(7)):e65669 doi:10.7759/cureus.65669.

    PMID: 39205702
  4. 4

    Spontaneous Hip Dislocation Complicating the Management of Malignant Peripheral Nerve Sheath Tumor Arising Within a Plexiform Neurofibroma.

    Mrowczynski OD, Vasekar M, Fox E, et al.

    Cureus 2021; (13(7)):e16320 doi:10.7759/cureus.16320.

    PMID: 34395108
  5. 5

    A rare presentation of thyroid malignant peripheral nerve sheath tumor in neurofibromatosis type 1 delineated by FDG PET/CT: A case report and literature review.

    Moghrabi S, Al-Hajaj N, Abu Aljaaz F, et al.

    Asia Oceania journal of nuclear medicine & biology 2024; (12(2)):174-178 doi:10.22038/AOJNMB.2024.76555.1539.

    PMID: 39050237
  6. 6

    Malignant Peripheral Nerve Sheath Tumor.

    James AW, Shurell E, Singh A, et al.

    Surgical oncology clinics of North America 2016; (25(4)):789-802.

    PMID: 27591499
  7. 7

    Discrimination of benign, atypical, and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 using diffusion-weighted MRI.

    Ristow I, Kaul MG, Stark M, et al.

    Neuro-oncology advances 2024; (6(1)):vdae021 doi:10.1093/noajnl/vdae021.

    PMID: 38468867
  8. 8

    Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study.

    Nishida Y, Ikuta K, Ito S, et al.

    Cancer science 2021; (112(3)):1114-1122 doi:10.1111/cas.14802.

    PMID: 33415792
  9. 9

    Atypical Neurofibromatous Neoplasm with Uncertain Biologic Potential in the Posterior Mediastinum of a Young Patient with Neurofibromatosis Type 1: A Case Report.

    Miyamoto K, Kobayashi H, Zhang L, et al.

    Case reports in oncology 2022; (15(3)):988-994 doi:10.1159/000526844.

    PMID: 36636686
  10. 10

    Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.

    Brahmi M, Thiesse P, Ranchere D, et al.

    PloS one 2015; (10(10)):e0138386 doi:10.1371/journal.pone.0138386.

    PMID: 26445379
  11. 11

    Clinical Outcomes Following Surgical Resection for Patients With Malignant Peripheral Nerve Sheath Tumors.

    Alfonzo Horowitz M, Khalifeh JM, Yang X, et al.

    Neurosurgery 2026; doi:10.1227/neu.0000000000003981.

    PMID: 41757904
  12. 12

    Clinicopathological study of malignant peripheral nerve sheath tumors in the head and neck: Case reports and review of literature.

    Li L, Ma XK, Gao Y, et al.

    World journal of clinical cases 2023; (11(25)):5910-5918 doi:10.12998/wjcc.v11.i25.5910.

    PMID: 37727493

This page is for educational purposes only and does not replace professional medical advice. If you notice rapid tumor growth, new pain, or changes in your NF1 symptoms, contact your healthcare provider immediately.

Get notified when new evidence is published on Neurofibromatosis type 1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.